Login
Toggle navigation
Videos
Categories
Trending
Frédéric Gardès' Opening Speech at the Conference: 'Innovations for Smart Mobility | Frédéric Gardès - CEO of Colas Group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Frédéric Gardès is the CEO of Colas Group
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Prashant Kumar on Reviving YES BANK and Future Growth Strategies | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
CEO giving opening speech|CEO, Binasat Communications Bhd
00:10:00
Discovering Opportunities in China: Insights from PAG's Weijian Shan | Weijian Shan, CEO, PAG.
00:10:00
Compound vs Simple Interest: Understanding the Difference | Mike Murkins - Financial Planner of Syverson Strege
00:10:00
Marc England Shares Investor Insights and Strategic Pathway for Genesis Energy | Marc England, CEO , Genesis Energy ltd.
00:00:00
Amanika Kumar, M.D. Gynecologic Oncologist, Mayo Clinic / Obesity and Endometrial Cancer – Mayo Clinic
00:10:00
Advice to Emerging Fund Managers:Principal at Colle Capital Partners|Doug Benowitz,Principal,Colle Capital Partners
00:10:00
Mats Rahmström on Leadership and Corporate Culture at Atlas Copco | In Good Company Podcast by Norges Bank Investment Management
00:10:00
Black Iron: Leading Iron Ore Project Ready for Construction with Strong Economic Fundamentals
00:10:00
Acuity Brands Welcomes Trevor Palmer as New President | Neil M. Ashe - Chairman, President And Chief Executive Officer of Acuity Brands Inc
00:10:00
Getting to Know Each Other: Occupational Health and Safety | Peng Huaisheng - CEO of Chinalco mining corp international
00:10:00
Avoiding the Financial Pitfalls: Top 5 Mistakes Couples in Their 30s and 40s Make and How to Prevent Them | Curt Stowers, CFP®, F5 Financial